Last reviewed · How we verify
NCT04707651: NASH
Formula Diet Treatment for NASH Patients.
NA trial testing Formula diet in Steatohepatitis, Nonalcoholic in 20 participants. Participants enrolled and being followed up; not accepting new ones.
31 December 2024
Quick facts
| Lead sponsor | West German Center of Diabetes and Health |
|---|---|
| Phase | NA |
| Status | Active, enrolled |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 20 |
| Start date | 18 January 2021 |
| Primary completion | 31 December 2024 |
| Estimated completion | 31 March 2025 |
| Sites | 2 locations across Germany |
Drugs / interventions tested
- Formula diet
Conditions studied
- Steatohepatitis, Nonalcoholic — all drugs for Steatohepatitis, Nonalcoholic →
Sponsor
West German Center of Diabetes and Health
Who can join
Adults 18 to 99, any sex, with Steatohepatitis, Nonalcoholic. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Non-alcoholic steatohepatitis (NASH) - also called fatty liver - is medically a serious problem because the liver tissue becomes fatty and stiff, and inflammatory reactions occur. This increases the risk of liver fibrosis (= scarring of the liver), liver cirrhosis (= shrunken liver), a liver tumor or death. So far there is no recognized treatment option for this disease. However, there is evidence that a lifestyle change based on a reduced carbohydrate diet, more exercise and a significant weight loss that can improve NASH.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04707651
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Formula diet
Trials testing the same drug.
- NCT05472272 — Low-Calorie Diets on Type 2 Diabetes Remission · NA · completed
Other recruiting trials for Steatohepatitis, Nonalcoholic
Currently open trials in the same condition.
- NCT07265297 — Using Hydroxychloroquine (HCQ) to Treat Steatohepatitis · Phase 3 · recruiting
- NCT06975579 — The COherence of Scatter Identification and Exclusion Algorithm Study · recruiting
- NCT06400771 — Safety of DNP007 in Healthy Subjects · Phase 1 · recruiting
- NCT06302049 — Clinical Study Evaluating the Safety and Efficacy of Esomeprazole in Treatment of Non-alcoholic Steatohepatitis · Phase 1, PHASE2 · recruiting
- NCT07007741 — Digital Therapy for Fatty Liver Disease · NA · recruiting
Other West German Center of Diabetes and Health trials
Trials by the same sponsor.
- NCT06745362 — Weight Reduction With the Low-Insulin-Method - Self Monitoring of Breath Acetone · NA · not yet recruiting
- NCT05933759 — Weight Reduction With the Low-Insulin-Method · NA · completed
- NCT05704491 — AI Screening for Diabetic Retinopathy · recruiting
- NCT04593992 — HTEMS Treatment of Diabetic Polyneuropathy · NA · completed
- NCT04474808 — Foot Cream for the Care of Dry and Cracked Skin · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04707651 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by West German Center of Diabetes and Health
- Last refreshed: 11 July 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04707651.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing